ARCHIVES

Gleevec Approval Sets Record For FDA Review: 73 Days

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

Interview: Joseph Jacobs Claims “Political Extortion” By The “Harkinites”

October 14, 1994

Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.

December 15, 2000

House-Senate Conferees Approve $6 Million Centers Amendment to Supplemental Appropriations Bill

June 27, 1986

Low Dose DFMO Reduces Colon Adenoma Recurrence

April 25, 2008

ASCO Releases Abstracts To 25,000, But Adds Warning On Stock Trading

April 19, 2002

Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms

April 6, 2012